Compagnie du Bois Sauvage has agreed to present its stake to the purchase offer of 100% of the securities of the company  OGEDA, formerly known as Euroscreen  ( www.ogeda.com ). This offer was launched by the listed company under Japanese law ASTELLAS PHARMA Inc., active on the pharmaceutical market.

As a consequence of this operation, Compagnie du Bois Sauvage should book during the first half of 2017 a positive non-recurring result of EUR 5.5 per share Cie du Bois Sauvage.

More information can be found in the press release to be published by the buyer (www.astellas.com).

This press release is available in French and Dutch. In the event of divergence, the French version shall be final.

Contact
Benoit DECKERS
Chief Executive
GSM: 0475 44 15 96